Envoyer ce communique par e-mail
Transgene and BioInvent Receive Approval From ANSM to Proceed With Phase I/IIa Trial of Anti-CTLA4-armed Oncolytic Virus BT-001 in Solid Tumors
*
Marquer les champs requis
Nom du destinataire:
*
Adresse e-mail du destinataire:
Message:
*
Enter security words: